Rapid-acting insulin analogues: No additional benefit for children with type 1 diabetes, research suggests

Friday, December 18, 2009 - 11:14 in Health & Medicine

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net